Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

26

Revenue 2017

Victoza

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Victoza was produced by Novo Nordisk.

Novo Nordisk will refile rejected diabetes duo in US

Novo Nordisk will refile rejected diabetes duo in US The decision also cast a shadow over the US development of Xultophy, a combination of insulin degludec and the active ingredient in Novo Nordisk's Victoza (liraglutide) that recently debuted in

Novo Nordisk sheds autoimmune portfolio to BMS

Novo Nordisk sheds autoimmune portfolio to BMS diabetes drug Victoza.

Sanofi on track to refile Lyxumia in US

Sanofi on track to refile Lyxumia in US Held back by the delay in the US, Lyxumia brought in 27m for Sanofi last year, well below other GLP-1 agonists including market leader Victoza (liraglutide) from Novo Nordisk which

Positive data in Saxenda diabetes prevention study

Positive data in Saxenda diabetes prevention study Saxenda - which is a high-dose formulation of the same drug used in Novo's big-selling diabetes therapy Victoza - was approved for obesity in the US towards the end of

Hanover wins Novo Nordisk public affairs and policy account

Hanover wins Novo Nordisk public affairs and policy account Novo has built its business on a range of diabetes, led by currently the insulins Levemir, NovoRapid and Tresiba and the GLP-1 agonist Victoza (liraglutide). ... The active ingredient of Victoza was also recently approved in Europe as the obesity

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
McCann Health Medical Communications

We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....

Latest intelligence

Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...
Patients are ready for virtual clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...

Infographics